Axogen, Inc. SEC Filing
Axogen, Inc. (AXGN) filed a Form 144 notice reporting a proposed open-market sale of 11,307 common shares with an aggregate market value of $206,316.82.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Axogen, Inc. (AXGN) filed a Form 144 notice reporting a proposed open-market sale of 11,307 common shares with an aggregate market value of $206,316.82. The filing lists the broker as Fidelity Brokerage Services LLC and indicates the shares are to be sold on NASDAQ with an approximate sale date of 10/03/2025. The securities were acquired in two open-market purchases on 08/23/2023 (7,600 shares) and 08/24/2023 (3,707 shares), paid in cash. The filing also discloses a prior sale on 10/02/2025 of 2,400 shares by the Elizabeth J Burke 2024 Irrevocable Trust for gross proceeds of $43,224.00. The filer affirms they are not aware of undisclosed material adverse information.
AI-generated analysis. How Rhea-AI works. Not financial advice.